MindWalk Holdings Corp. (HYFT)
| Market Cap | 63.90M -10.6% |
| Revenue (ttm) | 11.57M -35.6% |
| Net Income | -12.17M |
| EPS | -0.26 |
| Shares Out | 46.99M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 287,344 |
| Open | 1.300 |
| Previous Close | 1.310 |
| Day's Range | 1.270 - 1.400 |
| 52-Week Range | 0.990 - 2.990 |
| Beta | 0.83 |
| Analysts | Strong Buy |
| Price Target | 4.33 (+218.38%) |
| Earnings Date | Sep 14, 2026 |
About HYFT
MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
Financial Performance
In fiscal year 2026, MindWalk Holdings's revenue was 15.56 million, an increase of 46.41% compared to the previous year's 10.63 million. Losses were -13.95 million, -53.86% less than in 2025.
Financial numbers in CAD Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for HYFT stock is "Strong Buy." The 12-month stock price target is $4.33, which is an increase of 218.38% from the latest price.
News
MindWalk Holdings Slides: Investor presentation
MindWalk Holdings has posted slides in relation to its latest quarterly earnings report, which was published on September 15, 2026.
MindWalk Holdings Earnings Call Transcript: Q1 2027
Revenue grew 21% year-over-year to CAD 3.8 million, with gross margin expanding to 59%. Major investments in commercial infrastructure and platform partnerships drove a higher net loss, while a new $30 million credit facility enhances financial flexibility for scaling ReefIQ and advancing the pipeline.
MindWalk Holdings Earnings release: Q1 2027
MindWalk Holdings released its Q1 2027 earnings on September 14, 2026, summarizing the period's financial results.
MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today reported financial results for its fiscal 2027 first quarter ended Jul...
MindWalk enters binding commitment for $30M unsecured credit facility
MindWalk (HYFT) Holdings entered into a binding commitment with Sanabil for a senior unsecured revolving credit facility of up to $30M. The facility is intended to support MindWalk’s biologics program...
MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced that it has entered into a binding commitment with Sanabil (...
MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced that it is participating in the H.C. Wainwright 28th Annual ...
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk” or the “Company”) (NASDAQ: HYFT), a Bio-Native AI company, today announced that it will report financial results for t...
MindWalk Holdings Registration statement: Registration filing
MindWalk Holdings filed a registration statement on July 28, 2026, providing details about a securities offering with the SEC.
MindWalk showcases ReefIQ for AI drug discovery
MindWalk (HYFT) Holdings “unveiled the first public demonstration of ReefIQ, its biological context layer for AI drug discovery, running on AMD Instinct(TM) at AMD’s Advancing AI 2026 in San Francisco...
MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today unveiled the first public demonstration of ReefIQ™, its biological con...
MindWalk Holdings Earnings Call Transcript: Q4 2026
Revenue grew 46% year-over-year with gross margin expanding to 59%, while net loss narrowed by more than half. First recurring SaaS revenue was booked, and strategic divestitures strengthened the balance sheet. Market focus is shifting to proprietary data and context, validating the platform's unique position.
MindWalk Holdings Earnings release: Q4 2026
MindWalk Holdings released its Q4 2026 earnings on July 22, 2026, summarizing the period's financial results.
MindWalk Holdings Annual report: Q4 2026
MindWalk Holdings has published its Q4 2026 annual report on July 22, 2026.
MindWalk Holdings Slides: Q4 2026
MindWalk Holdings has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on July 22, 2026.
MindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today reported financial results for the fiscal year ended April 30, 2026. A...
MindWalk files $250M mixed securities shelf
16:06 EDT MindWalk (HYFT) files $250M mixed securities shelf
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2026 on July 22, 2026
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk” or the “Company”) (NASDAQ: HYFT), a Bio-Native AI company, today announced that it will report financial results for t...
MindWalk Holdings Registration statement: Registration filing
MindWalk Holdings filed a registration statement on July 13, 2026, providing details about a securities offering with the SEC.
MindWalk added to Russell 3000E Index
MindWalk (HYFT) Holdings has been added to the Russell 3000E Index, effective after the U.S. market close on June 26, as part of the FTSE Russell June 2026 semi-annual Russell…
MindWalk Holdings Corp. (NASDAQ: HYFT) Added to the Russell 3000E Index, Expanding Institutional Investment Opportunity
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today announced that it has been added to the Russell 3000E Index, effective...
MindWalk files European patent application for high-dimensional data structures
MindWalk (HYFT) Holdings announced the filing of European patent application No. EP26187897.9, directed to high-dimensional data structures for biological subsequences and property inference. The appl...
MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today announced the filing of European patent application No. EP26187897.9, ...
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a bio-native AI company, today announced that President and Chief Executive Officer Dr. Jennifer Bath...
MindWalk launches ReefIQ context layer
MindWalk (HYFT) Holdings launched ReefIQ, a HYFT-powered biological context layer for AI drug discovery and biologics development, that sits between client discovery data and AI reasoning workflows. B...